Healthcare Success

JULY 18, 2022

The healthcare industry is constantly evolving, and it’s essential for all healthcare businesses—and their websites—to evolve to stay competitive. Likewise, to stay relevant in the face of constant change, our agency's business model and clientele have changed multiple times since our founding in 2006.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

European Pharmaceutical Review

NOVEMBER 16, 2023

To support biosimilar adoption and expand access for patients in Europe, measures must be taken to reduce the cost of developing biosimilars” Since their introduction in 2006, biosimilars have generated more than €30 billion in cumulative savings for European healthcare systems as of 2022, an IQVIA report from last year highlighted.

Marketing 110

Marketing Education Competition Consulting 110

World of DTC Marketing

JANUARY 31, 2021

2wo: The number of mergers and acquisitions(M&A) involving one of the top 25 firms in the pharmaceutical industry more than doubled from 2006 to 2016, and the practice doesn’t seem to be abating. Can you imagine the return on a potential cancer vaccine? The cost is estimated to be in the billions. By the way, Ms.

Pharma 187

Pharma Insurance Pharmaceutical Healthcare 187

Healthcare Success

APRIL 20, 2023

At Healthcare Success, we have been sharing marketing knowledge, tips, and tricks since our agency’s founding in 2006. Start With Some Classics Whether you’re a new marketer or a seasoned professional, take a deep dive into essential topics that can significantly impact your healthcare business.

Healthcare 52

Healthcare Healthcare Marketing Media 52

Pharmaceutical Technology

APRIL 19, 2023

Following Bayer’s takeover of Schering Healthcare in 2006, where it inherited the oral contraceptive Yasmin (ethinyl estradiol + drospirenone) and the intrauterine device Mirena (levonorgestrel-releasing system), the German drugmaker has become one of the world’s leading pharmaceutical specialists in women’s health.

Healthcare 52

Healthcare Healthcare Leads Pharmaceutical 52

Healthcare Success

JULY 5, 2022

(Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Every time I run into someone who is faced with the daunting challenge of marketing to doctors or other healthcare professionals, I giggle empathetically and say, “I feel your pain.”. Conclusion.

Doctors 57

Doctors Physicians Marketing Healthcare 57

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS represents five Amryt ordinary shares. billion, with upfront consideration of $1.25 on 6 th January.

Pharma 87

Pharma Biopharma Management Medicine 87

Clarivate

AUGUST 28, 2024

The continued strength of HUMIRA in France is particularly remarkable, Parisi noted, given that biosimilars are better entrenched in Europe, where a biosimilar was first approved in 2006. In the U.S.,

Prescription 59

Prescription Marketing Patients Physicians 59

European Pharmaceutical Review

SEPTEMBER 21, 2023

The impact of a one-time gene therapy treatment on national health budgets must also be considered, particularly at a time when many healthcare systems are facing financial challenges. Economic uncertainties can therefore lie in the high cost involved in drug development, manufacturing and delivery.

Pharmaceutical 96

Pharmaceutical Food and Drug Administration Medicine Patients 96

European Pharmaceutical Review

AUGUST 23, 2022

We hope that this article serves draws attention from the community and makes funding agencies aware of this imperative healthcare sustainability problem. World Health Organization; 2006. About the author. References. Counterfeit medicines. Available from: [link]. The Guardian. 2019; Available from: [link].

Medicine 98

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 19, 2022

European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006″ European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006. References/Endnotes. Biosimilars in the EU.

Medicine 52

Medicine Biopharma Safety Food 52

PM360

MARCH 7, 2023

After a four-decade career in advertising, the founding of two celebrated healthcare agencies (Wishbone in 1998 and Calcium in 2012), and countless accolades, Steven Michaelson has announced his retirement from Calcium + Company. And in 2022, Calcium was named on MM+M’s Best Places to Work list.

Education 52

Education Healthcare Healthcare Pharma 52

pharmaphorum

OCTOBER 13, 2022

He specialises in working with clients to develop innovative solutions as they evolve to meet the needs of a changing healthcare and business landscape. Until July of 2006, Mr. Baxter was SVP, R&D Finance and Operations, of GlaxoSmithKline (GSK). Jeff Baxter – President and CEO, VBI Vaccines.

Management 52

Management Pharma Consulting Leads 52

Pharmaceutical Technology

MARCH 22, 2023

Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Fresenius Kabi is a global healthcare company specialising in medicines and technologies for infusion, transfusion and clinical nutrition. In 2020, Fresenius Kabi introduced their first RFID-enabled medication, Diprivan +RFID.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma Pharmaceutical products 105

pharmaphorum

JANUARY 24, 2023

The cost of testing per human genome in 2006 was approximately $14 million , and in less than two decades, an average consumer-purchased genetic test costs $100. The same is becoming true for the healthcare industry, and one of the first major breakthroughs in the area was the 100,000 Genomes Project. appeared first on.

Food and Drug Administration 86

Food and Drug Administration Pharma Medicine Healthcare 86

Clarivate

NOVEMBER 13, 2023

Last year alone the Clarivate COA team conducted over 300 interviews with patients, caregivers or healthcare professionals. The PFDD series will eventually take the place of the PRO Guidance for Industry. We developed or explored over 100 COAs and achieved ethical approval in multiple countries including the U.S., Mainland China and Japan.

Patients 52

Patients Food and Drug Administration FDA Safety 52

pharmaphorum

NOVEMBER 9, 2022

The campaign captures the vibrancy of the haemophilia community – including people from different backgrounds, ages, and countries, highlighting their experiences as children, adults, parents, advocates, healthcare professionals, and caregivers. About the author.

Management 86

Management Patients Sales goal Medical 86

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Education 59

World of DTC Marketing

DECEMBER 10, 2020

In November 2017, a study published in JAMA Internal Medicine examined the costs of developing 10 cancer drugs approved by the FDA from 2006 to 2015 and provided a strong contrast to the Tufts study from a year before.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharmaceutical Technology

MARCH 24, 2023

Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. The success or failure of Humira biosimilars will represent the latest test of biosimilars attempting to reduce US healthcare spending and improve public health.

Competition 59

Competition Marketing FDA Physicians 59

Clarivate

NOVEMBER 10, 2022

The evidence standards that a COA must meet to support key clinical trial endpoints have become increasingly stringent in recent decades, following the introduction of the United States Food and Drug Administration (FDA) Patient Reported Outcomes (PRO) draft guidance in 2006, followed by the full guidance in 2009.

Patients 52

Patients Food and Drug Administration FDA Safety 52

pharmaphorum

AUGUST 4, 2022

When it comes to recruitment, the pharmaceutical industry should be well placed to capitalise on a society that now has healthcare front of mind. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. Raising the profile. She joined NSF in 2017. appeared first on.

Recruitment 93

Recruitment Pharma Training Pharmaceutical manufacturing 93

PM360

SEPTEMBER 28, 2022

Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar being approved in Europe in 2006. From that point in 2006 all the way to where we are currently today, there has been a very dramatic evolution of these products. And it really all attests to one word: education. The third foundation is value.

Competition 98

Competition Marketing Manufacturing Biopharma 98

World of DTC Marketing

JUNE 4, 2021

A 2006 report by the Institute of Medicine helped establish how the rise in obesity among kids corresponds to the increased marketing of unhealthy food and drinks to them. Sugary, oily foods are engineered to be consumed often and in big portions. But we’re not just influenced by their irresistible taste.

Food 207

Food Insurance Leads Medical 207

Pharmaceutical Technology

FEBRUARY 24, 2023

The post Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict appeared first on Pharmaceutical Technology.

Pharma 64

Pharma Medicine Competition Marketing 64

Clarivate

SEPTEMBER 25, 2024

2006 Dec 7;355(23):2408-17. Rev Bras Hematol Hemoter. 2011;33(6):470-5. [14] 14] Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. appeared first on Clarivate.

Medicine 59

Medicine Side effects Patients Pharmaceutical 59

CloserIQ

OCTOBER 10, 2018

Founded 2006. Founded 2006. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Devoted Health is a healthcare company that helps seniors navigate the complex healthcare system. Founded 2006.

Sales 76

Sales Management Education Marketing 76

European Pharmaceutical Review

NOVEMBER 4, 2022

Nevertheless, studies have shown that oral delivery remains a preferred method in terms of patient compliance, 3 overall healthcare costs and convenience. 2006 [cited 7 September 2022];17(5):735-749. Nevertheless, it is one that would benefit from improvement in both its route of administration as well as its toxicity profile”.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical FDA Patients 98

Pharmaceutical Technology

NOVEMBER 24, 2022

At Quotient Sciences, our state-of-the-art facilities follow cGMP guidelines for the production of 14 C-labeled pharmaceuticals for human investigations and are accredited by the UK Medicines and Healthcare products Regulatory Agency (MHRA). How does your unique Synthesis-to-Clinic® offering streamline the drug development process?

Manufacturing 52

Manufacturing Pharmaceutical Specialization Medicine 52

Celeritas

NOVEMBER 21, 2022

The advantages of nanotechnology in the healthcare of animals and humans are almost limitless. Enabling communication and cooperation in bio-nanosensor networks: toward innovative healthcare solutions. Cham: Springer International Publishing; 2018:323–334. [5] 5] Agoulmine N, Kim K, Kim S, Rim T, Lee JS, Meyyappan M. IEEE Wirel Commun.

Engineering 52

Engineering Transportation Side effects Networking 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Medical 117

Medical Government Marketing Medicine 117

Pharmaceutical Technology

OCTOBER 5, 2008

According to market intelligence provider Pharmaceutical Insights, Japan’s $6m generic drug sector is currently experiencing a renaissance, primarily because the government wants to control healthcare costs. Like in many other sectors, China and India are the ones labelled as those which will lead the expansion.

Government 52

Government Marketing Pharmaceutical Physicians 52

Pharmaceutical Technology

JULY 10, 2008

The past Global figures from PwC show that in 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old. “In 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old.”

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

pharmaphorum

JANUARY 12, 2023

The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made access to the drugs easier.

Pharmacology 52

Pharmacology Retail Healthcare Provider FDA 52

Healthcare Success

OCTOBER 30, 2024

Can healthcare organizations leverage influencer marketing to authentically connect with high-value patients and referring doctors, while staying compliant and brand safe? Getting into influencer marketing in healthcare might seem risky, but it doesn’t have to be.

Marketing 107

Marketing Healthcare Healthcare Networking 107

Clarivate

NOVEMBER 14, 2023

The first GLP-1 RA used for diabetes (short-acting exenatide) became available in 2005 (US)/2006 (Europe) and required twice-daily injection. Since then, two GLP‑1 RAs requiring only once-daily injection have become available, followed by three which require only once-weekly injection (Figure 1). [7]

Food and Drug Administration 52

Food and Drug Administration Medicine Patients Food 52

Pharmaceutical Technology

JULY 23, 2008

“There’s a huge clinical need which has been undelivered for years,” says Gustav Ando, manager of the healthcare business development unit [HBDU] at Global Insight. All those people need treatment, which creates demand for drugs and stimulates growth in the sector.

Side effects 52

Side effects Marketing Pharmaceutical Sales 52